Prioritizing FDA approved therapeutics for treating sepsis phenotypes: A network modeling approach based on neutrophil proteomics.
Saved in:
| Title: | Prioritizing FDA approved therapeutics for treating sepsis phenotypes: A network modeling approach based on neutrophil proteomics. |
|---|---|
| Authors: | Langston JC; Department of Bioengineering, Temple University, Philadelphia, PA, United States., Liu D; Department of Bioengineering, Temple University, Philadelphia, PA, United States., Yang Q; Department of Mechanical Engineering, Temple University, Philadelphia, PA, United States., Merali S; School of Pharmacy, Temple University, Philadelphia, PA, United States., Merali C; School of Pharmacy, Temple University, Philadelphia, PA, United States., Singh N; Biotechnology, Energy, and Materials Division, CFD Research Corporation, Huntsville, AL, United States., Fisher JL; Biotechnology, Energy, and Materials Division, CFD Research Corporation, Huntsville, AL, United States., Prabhakarpandian B; Biotechnology, Energy, and Materials Division, CFD Research Corporation, Huntsville, AL, United States., Kilpatrick LE; Center for Inflammation and Lung Research, Department of Microbiology, Immunology and Inflammation, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States., Kiani MF; Department of Bioengineering, Temple University, Philadelphia, PA, United States.; Department of Mechanical Engineering, Temple University, Philadelphia, PA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Aug 14; Vol. 16, pp. 1646141. Date of Electronic Publication: 2025 Aug 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1646141 |
